These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 22841250

  • 21. Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression.
    Miller JT, Collins CD, Stuckey LJ, Luan FL, Englesbe MJ, Magee JC, Park JM.
    Pharmacotherapy; 2009 Oct; 29(10):1166-74. PubMed ID: 19792990
    [Abstract] [Full Text] [Related]

  • 22. Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers.
    Opelz G, Morath C, Süsal C, Tran TH, Zeier M, Döhler B.
    Transplantation; 2015 Feb; 99(2):400-4. PubMed ID: 25050471
    [Abstract] [Full Text] [Related]

  • 23. Three-year posttransplant graft survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple-drug regimen.
    Irish W, Sherrill B, Brennan DC, Lowell J, Schnitzler M.
    Transplantation; 2003 Dec 27; 76(12):1686-90. PubMed ID: 14688516
    [Abstract] [Full Text] [Related]

  • 24. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML, Ahsan N, Wadei HM, Genco PV, Geiger XJ, Willingham DL, Taner CB, Hewitt WR, Grewal HP, Nguyen JH, Hughes CB, Gonwa TA.
    Transplantation; 2009 Jan 27; 87(2):227-32. PubMed ID: 19155977
    [Abstract] [Full Text] [Related]

  • 25. Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients.
    Khanmoradi K, Knorr JP, Feyssa EL, Parsikia A, Jawa P, Dinh DB, Campos S, Zaki RF, Ortiz JA.
    Exp Clin Transplant; 2013 Jun 27; 11(3):222-8. PubMed ID: 23432665
    [Abstract] [Full Text] [Related]

  • 26. Annual trends and triple therapy--1991-2000.
    Nishikawa K, Terasaki PI.
    Clin Transpl; 2001 Jun 27; ():247-69. PubMed ID: 12211788
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The efficacy and safety of high-dose mizoribine in ABO-incompatible kidney transplantation using anti-CD20 and anti-CD25 antibody without splenectomy treatment.
    Yoshimura N, Ushigome H, Matsuyama M, Nobori S, Suzuki T, Sakai K, Okajima H, Okamoto M.
    Transplant Proc; 2012 Jan 27; 44(1):140-3. PubMed ID: 22310599
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Improved graft survival in ABO-incompatible living donor kidney transplantation.
    Kaihara S, Okamoto M, Akioka K, Ogino S, Higuchi A, Kadotani Y, Nobori S, Yoshimura N.
    Transplant Proc; 2005 May 27; 37(4):1804-5. PubMed ID: 15919472
    [Abstract] [Full Text] [Related]

  • 35. Role of donor age and acute rejection episodes on long-term graft survival in cadaveric kidney transplantations.
    Emiroğlu R, Yagmurdur MC, Karakayali F, Haberal C, Ozcelik U, Colak T, Haberal M.
    Transplant Proc; 2005 Sep 27; 37(7):2954-6. PubMed ID: 16213272
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.